Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SOTAC PHARMACEUTICALS LTD. vs EMCURE PHARMACEUTICALS LTD. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SOTAC PHARMACEUTICALS LTD. EMCURE PHARMACEUTICALS LTD. SOTAC PHARMACEUTICALS LTD./
EMCURE PHARMACEUTICALS LTD.
 
P/E (TTM) x - - - View Chart
P/BV x 2.9 8.3 35.2% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 SOTAC PHARMACEUTICALS LTD.   EMCURE PHARMACEUTICALS LTD.
EQUITY SHARE DATA
    SOTAC PHARMACEUTICALS LTD.
Mar-24
EMCURE PHARMACEUTICALS LTD.
Mar-24
SOTAC PHARMACEUTICALS LTD./
EMCURE PHARMACEUTICALS LTD.
5-Yr Chart
Click to enlarge
High Rs155NA-   
Low Rs97NA-   
Sales per share (Unadj.) Rs94.0367.6 25.6%  
Earnings per share (Unadj.) Rs3.229.1 11.1%  
Cash flow per share (Unadj.) Rs6.046.4 13.0%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Avg Dividend yield %00- 
Book value per share (Unadj.) Rs41.0162.2 25.3%  
Shares outstanding (eoy) m11.05181.15 6.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30-   
Avg P/E ratio x38.90-  
P/CF ratio (eoy) x20.80-  
Price / Book Value ratio x3.10-  
Dividend payout %010.3 0.0%   
Avg Mkt Cap Rs m1,3920-   
No. of employees `000NANA-   
Total wages/salary Rs m2012,921 0.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,03866,583 1.6%  
Other income Rs m5570 0.9%   
Total revenues Rs m1,04367,152 1.6%   
Gross profit Rs m8312,198 0.7%  
Depreciation Rs m313,124 1.0%   
Interest Rs m172,371 0.7%   
Profit before tax Rs m407,272 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m41,997 0.2%   
Profit after tax Rs m365,276 0.7%  
Gross profit margin %8.018.3 43.7%  
Effective tax rate %9.727.5 35.3%   
Net profit margin %3.47.9 43.5%  
BALANCE SHEET DATA
Current assets Rs m60642,599 1.4%   
Current liabilities Rs m43732,105 1.4%   
Net working cap to sales %16.315.8 103.4%  
Current ratio x1.41.3 104.5%  
Inventory Days Days926 36.1%  
Debtors Days Days924102 906.9%  
Net fixed assets Rs m43334,495 1.3%   
Share capital Rs m1111,812 6.1%   
"Free" reserves Rs m34227,566 1.2%   
Net worth Rs m45329,378 1.5%   
Long term debt Rs m1217,666 1.6%   
Total assets Rs m1,03977,094 1.3%  
Interest coverage x3.34.1 80.7%   
Debt to equity ratio x0.30.3 102.7%  
Sales to assets ratio x1.00.9 115.7%   
Return on assets %5.19.9 51.6%  
Return on equity %7.918.0 44.0%  
Return on capital %9.926.0 38.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-16110,972 -1.5%  
From Investments Rs m-197-7,125 2.8%  
From Financial Activity Rs m295-1,642 -18.0%  
Net Cashflow Rs m-632,185 -2.9%  

Share Holding

Indian Promoters % 72.9 77.9 93.6%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 8.9 6.9 129.3%  
FIIs % 8.9 2.9 305.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 27.2 21.9 123.9%  
Shareholders   251 152,914 0.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SOTAC PHARMACEUTICALS LTD. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SOTAC PHARMACEUTICALS LTD. vs EMCURE PHARMACEUTICALS LTD.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SOTAC PHARMACEUTICALS LTD. vs EMCURE PHARMACEUTICALS LTD. Share Price Performance

Period SOTAC PHARMACEUTICALS LTD. EMCURE PHARMACEUTICALS LTD. S&P BSE HEALTHCARE
1-Day 0.00% -1.67% 0.11%
1-Month 0.38% -11.78% -3.22%
1-Year -7.60% -5.49% 42.65%
3-Year CAGR -0.77% -1.87% 19.86%
5-Year CAGR -0.46% -1.12% 25.90%

* Compound Annual Growth Rate

Here are more details on the SOTAC PHARMACEUTICALS LTD. share price and the EMCURE PHARMACEUTICALS LTD. share price.

Moving on to shareholding structures...

The promoters of SOTAC PHARMACEUTICALS LTD. hold a 72.9% stake in the company. In case of EMCURE PHARMACEUTICALS LTD. the stake stands at 78.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SOTAC PHARMACEUTICALS LTD. and the shareholding pattern of EMCURE PHARMACEUTICALS LTD..

Finally, a word on dividends...

In the most recent financial year, SOTAC PHARMACEUTICALS LTD. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

EMCURE PHARMACEUTICALS LTD. paid Rs 3.0, and its dividend payout ratio stood at 10.3%.

You may visit here to review the dividend history of SOTAC PHARMACEUTICALS LTD., and the dividend history of EMCURE PHARMACEUTICALS LTD..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.